Top Markets
Coin of the day
Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

PTPI
Classifica tra le azioni #40451
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Prezzo delle azioni
$0.0034
Capitalizzazione di mercato
$144.07K
Variazione (1 giorno)
13.33%
Variazione (1 anno)
-88.67%
Paese
US
Scambia Petros Pharmaceuticals, Inc. (PTPI)

Categoria

Storico del rendimento da dividendi per Petros Pharmaceuticals, Inc. (PTPI)
Il rendimento da dividendi (TTM) di Petros Pharmaceuticals, Inc. (simbolo azionario: PTPI) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Petros Pharmaceuticals, Inc. (PTPI) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti